Trillium Therapeutics Inc. (NASDAQ:TRIL): Are Hedge Funds Right About This Stock?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Walleye Capital Will England | 0 | $0 | 0% | |
| 2. | Anson Investments Amin Nathoo And Moez Kassam | 0 | $0 | 0% | |
| 3. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% | |
| 4. | D E Shaw D. E. Shaw | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.00 | 3,646 | $32,814.00 | 0 | 2021-07-07 | Filing | |
| $8.27 | 3,646 | $30,152.42 | 0 | 2021-06-07 | Filing | |
| $9.24 | 23,802 | $219,880.50 | 0 | 2021-05-12 | Filing | |
| $9.20 | 106,698 | $981,802.99 | 0 | 2021-05-11 | Filing | |
| $9.30 | 3,646 | $33,907.80 | 0 | 2021-05-07 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% |